Summary & Overview
HCPCS L8606: Injectable Urinary Tract Bulking Agent, 1 ml Syringe
HCPCS Level II code L8606 designates a synthetic injectable bulking agent supplied in a 1 ml syringe for urinary tract implantation and includes shipping and necessary supplies. The code is used in billing for the supply component of urethral or periurethral bulking procedures commonly performed to treat stress urinary incontinence and other urinary tract insufficiencies. Nationally, supply codes like L8606 matter because they capture discrete implant and material costs separate from professional and facility services, affecting coverage determinations and patient cost-sharing.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical settings where the supply is used, and the types of benchmarks and policy considerations that affect coverage and reimbursement for injectable urinary bulking agents. The publication summarizes common payer approaches to supply code reimbursement, identifies where policy variations typically occur, and outlines the billing and coding context needed to align claims and preauthorization processes.
The report does not provide clinical recommendations. It focuses on coding definition, service setting implications, and the billing considerations that influence national payer coverage and cost allocation for injectable urinary bulking implants.
Billing Code Overview
HCPCS Level II code L8606 describes an injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies. This itemized supply code covers a prefilled 1 ml syringe of a synthetic urethral bulking implant intended to provide tissue augmentation within the urinary tract.
Service type: Injectable implant supply for urinary tract bulking procedures
Typical site of service: Outpatient clinic or ambulatory surgical center (procedure performed in a urology or gynecology setting)
Clinical & Coding Specifications
Clinical Context
A typical patient is a woman presenting to a urology or urogynecology clinic with symptomatic stress urinary incontinence (SUI) refractory to conservative measures (pelvic floor physical therapy, pessary). After clinical evaluation and urodynamic testing as indicated, the clinician performs a periurethral injection of a synthetic bulking agent (L8606) in a procedure suite or ambulatory surgical center. The workflow includes pre-procedure counseling, verification of informed consent, sterile preparation, local anesthesia or light sedation as indicated, cystoscopic or transurethral guidance for periurethral injection of the 1 mL synthetic implant, monitoring for immediate complications (urinary retention, hematuria, infection), and brief post-procedure observation prior to discharge with follow-up arranged for symptomatic assessment and potential repeat injections.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Physician or other qualified health professional service | Use when the service is the usual, customary, and reasonable (standard) encounter. |
22 | Increased procedural services |